Regulation of Glut 1 Function

Glut 1 功能的调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Glut1 glucose transporter is an integral plasma membrane protein that is expressed in many cells and tissues. We have found that the acute (1-2 h) stimulation of Glut 1-mediated glucose transport is controlled by "activation "' of Glut1 transporters pre-existing in the plasma membrane. We have also found that a fraction of cell Glut 1 is bound by stomatin resulting in inhibition of Glut1 function. More recently we have made the novel observation that a significant fraction of Glut1, and virtually all of stomatin, reside in the cholesterol- and sphingolipid-rich detergent-resistant membranes (DRMs), and that a fraction of Glut l (but not stomatin) moves out of the DRMs upon stimulation of glucose transport in response to inhibition of oxidative phosphorylation. Based on our results we propose that Glut 1 localized in the plasma membrane exists in two-states, namely inactive and active. This proposal will be tested by the following Specific Aims: 1) Test the hypothesis that association of stomatin and Glutl leads to inhibition of Glut1 function, 2) Test the hypothesis that Glutl dissociates from stomatin during its activation in response to inhibition of oxidative phosphorylation and following stimulation of AMP-activated protein kinase (AMPK), 3) Test the hypothesis that Glut l present in plasma membrane DRMs are palmitoylated and the movement of Glutl out of this micro-domain reflects its de-palmitoylation, and 4) Identify Glutl-binding proteins under basal and stimulated conditions. An understanding of the molecular events leading to control of Glut l function should provide new insights into potentially novel physiological and pharmacological regulators of this important transporter.
描述(由申请人提供):GLUT1葡萄糖转运蛋白是一种积分的质膜蛋白,在许多细胞和组织中表达。我们发现,急性(1-2 h)刺激GLUT 1介导的葡萄糖转运受到质膜中存在的GLUT1转运蛋白的“激活”。我们还发现,细胞GLUT 1的一部分受阳性蛋白结合,从而抑制GLUT1功能。最近,我们对胆固醇和富含鞘脂的耐药膜(DRM)(DRMS)的大量glut1以及几乎所有的臭蛋白都进行了新的观察,几乎所有的凝血蛋白都存在,而Glut L(但不是臭头豆)的一小部分在刺激粘液量促进氧化量的刺激范围内将DRMS移出。根据我们的结果,我们提出,在两态中存在于质膜中的GLUT 1,即无活性和活性。 This proposal will be tested by the following Specific Aims: 1) Test the hypothesis that association of stomatin and Glutl leads to inhibition of Glut1 function, 2) Test the hypothesis that Glutl dissociates from stomatin during its activation in response to inhibition of oxidative phosphorylation and following stimulation of AMP-activated protein kinase (AMPK), 3) Test the hypothesis that Glut l present in质膜DRM被棕榈酰粘层,而从该微域中移动glutll,反映了其去甲状腺素,4)在基础和刺激的条件下鉴定出GLUTL结合蛋白。 对导致控制Glut L功能的分子事件的理解应为对该重要转运蛋白的潜在新型生理和药理调节剂提供新的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

FARAMARZ ISMAIL-B...的其他基金

Molecular engineering of complementary glucose-responsive conformational switches in insulin and glucagon
胰岛素和胰高血糖素中互补葡萄糖响应构象开关的分子工程
  • 批准号:
    10263301
    10263301
  • 财政年份:
    2020
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Molecular endocrinology and principles of diabetes therapeutics: application to ultra-stable insulin analogs
分子内分泌学和糖尿病治疗原理:超稳定胰岛素类似物的应用
  • 批准号:
    10155480
    10155480
  • 财政年份:
    2020
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Molecular engineering of complementary glucose-responsive conformational switches in insulin and glucagon
胰岛素和胰高血糖素中互补葡萄糖响应构象开关的分子工程
  • 批准号:
    10443890
    10443890
  • 财政年份:
    2020
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Novel PET Imaging of Glucose Transport
葡萄糖转运的新型 PET 成像
  • 批准号:
    7730065
    7730065
  • 财政年份:
    2009
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Novel PET Imaging of Glucose Transport
葡萄糖转运的新型 PET 成像
  • 批准号:
    8110071
    8110071
  • 财政年份:
    2009
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Novel PET Imaging of Glucose Transport
葡萄糖转运的新型 PET 成像
  • 批准号:
    7884582
    7884582
  • 财政年份:
    2009
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Novel PET Imaging of Glucose Transport
葡萄糖转运的新型 PET 成像
  • 批准号:
    8322155
    8322155
  • 财政年份:
    2009
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Regulation of Glut 1 Function
Glut 1 功能的调节
  • 批准号:
    6771818
    6771818
  • 财政年份:
    2003
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Regulation of Glut 1 Function
Glut 1 功能的调节
  • 批准号:
    7070598
    7070598
  • 财政年份:
    2003
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Regulation of Glut 1 Function
Glut 1 功能的调节
  • 批准号:
    6882034
    6882034
  • 财政年份:
    2003
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:

相似国自然基金

细胞膜微区对类受体激酶PEPR1寡聚化及功能的调控机制研究
  • 批准号:
    32370740
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
脂多糖修饰酶EptA对细胞膜脂质相分离的响应机制研究
  • 批准号:
    32301041
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
甘草酚通过肠胶质细胞GDNF/RET途径促进ZO-1与肠上皮细胞膜融合保护肠粘膜机械屏障的作用与机制研究
  • 批准号:
    82304147
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
乳酸亚致死沙门氏菌细胞膜损伤及其机制研究
  • 批准号:
    32302156
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
激活核受体PPARα-脂肪酸β氧化调控轴减轻抗磷脂抗体引起的肾血管内皮细胞膜磷脂合成增加和过氧化介导的铁死亡
  • 批准号:
    82300481
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
  • 批准号:
    10749672
    10749672
  • 财政年份:
    2024
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Investigating the molecular mechanisms of membrane remodeling by coronaviruses
研究冠状病毒膜重塑的分子机制
  • 批准号:
    10724399
    10724399
  • 财政年份:
    2023
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Inducing Off-pathway Assembly of HIV Gag Polyprotein with Computationally Designed Peptides
用计算设计的肽诱导 HIV Gag 多蛋白的非途径组装
  • 批准号:
    10724495
    10724495
  • 财政年份:
    2023
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Tau protein proteolysis signaling in Alzheimer's disease
阿尔茨海默病中的 Tau 蛋白水解信号
  • 批准号:
    10728202
    10728202
  • 财政年份:
    2023
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别:
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
  • 批准号:
    10655891
    10655891
  • 财政年份:
    2023
  • 资助金额:
    $ 32.51万
    $ 32.51万
  • 项目类别: